Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Optimization of Growth Factor Enhanced Small Intestinal Submucosa - Extracellular Matrix Biomaterial for Epicardial Infarct Repair

EF 2015-16

Résumé
The prevalence of congestive heart failure (HF) is dangerously high and is on the rise as developments in medical interventions result in greater survival rates for patients who had heart attacks. It is associated with significant mortality rates and health care costs and affects over 500,000 people in Canada. Following a heart attack, cells in the heart called fibroblasts alter the matrix of the heart. The matrix is the glue that holds the cells together to form tissues. These fibroblasts breakdown and rebuild the matrix causing changes in structure and function. This can lead to heart failure over time.We propose an innovate surgical strategy to prevent congestive heart failure. Previous work in an animal model has shown that a three-dimensional patch material (SIS-ECM) can be sewn onto the surface of the heart to improve the healing process and heart function following a heart attack. Additionally, our work has shown that the healing properties of this patch can be improved by adding growth factors (FGF-2). However, simply adding growth factors to this patch is inefficient and costly, acting as a barrier to its translational feasibility into a cardiac surgery operating room. Preliminary work has shown that adding a molecule, called heparin, can increase the amount of growth factor loaded onto this patch. This project will examine the effects of this growth factor and heparin enhanced patch on human heart cells obtained from patients undergoing open-heart surgery (with consent). It will provide important preliminary data for the development of a new surgical operation for patients after heart attacks. We aim to prevent congestive heart failure leading to improved clinical outcomes and better quality of life for patients following a heart attack.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
350125
Name
Park Daniel S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Optimization of Growth Factor Enhanced Small Intestinal Submucosa - Extracellular Matrix Biomaterial for Epicardial Infarct Repair
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomaterials; Cardiac Fibroblast; Cardiac Fibrosis; Congestive Heart Failure; Extracellular Matrix; Growth Factors; Tissue Engineering
Abstract
The prevalence of congestive heart failure (HF) is dangerously high and is on the rise as developments in medical interventions result in greater survival rates for patients who had heart attacks. It is associated with significant mortality rates and health care costs and affects over 500,000 people in Canada. Following a heart attack, cells in the heart called fibroblasts alter the matrix of the heart. The matrix is the glue that holds the cells together to form tissues. These fibroblasts breakdown and rebuild the matrix causing changes in structure and function. This can lead to heart failure over time.We propose an innovate surgical strategy to prevent congestive heart failure. Previous work in an animal model has shown that a three-dimensional patch material (SIS-ECM) can be sewn onto the surface of the heart to improve the healing process and heart function following a heart attack. Additionally, our work has shown that the healing properties of this patch can be improved by adding growth factors (FGF-2). However, simply adding growth factors to this patch is inefficient and costly, acting as a barrier to its translational feasibility into a cardiac surgery operating room. Preliminary work has shown that adding a molecule, called heparin, can increase the amount of growth factor loaded onto this patch. This project will examine the effects of this growth factor and heparin enhanced patch on human heart cells obtained from patients undergoing open-heart surgery (with consent). It will provide important preliminary data for the development of a new surgical operation for patients after heart attacks. We aim to prevent congestive heart failure leading to improved clinical outcomes and better quality of life for patients following a heart attack.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Park, Daniel S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~